2 terminated, 1 completed, 1 recruiting. 2 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Terminated 1 |
| Phase 1 | 1 | Terminated 1 |
| Phase 3 | 1 | Recruiting 1 |
Follow eritoran: new trials by email Literature Review of eritoran trials Research Report on eritoran
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia Ceftriaxone + Macrolide, Moxifloxacin or Levofloxacin, Piperacillin-tazobactam + Macrolide - Respiratory Tract Diseases, Influenza (Pandemic) | Phase 3 | Recruiting | UMC Utrecht | 20000 | 2016-04-11 | 2026-11-04 |
| The Effect of TLR4 Inhibition in Obese and Type 2 Diabetic Subjects Eritoran, D5W - Insulin Sensitivity | Phase 2 | Terminated | The University of Texas Health Science Center at San Antonio | 15 | 2015-01-01 | 2020-03-04 |
| The Role of TLR4 on Lipid-induced Insulin Resistance Eritoran, D5W (5% Dextrose in water) - Insulin Sensitivity | Phase 2 | Completed | The University of Texas Health Science Center at San Antonio | 10 | 2015-01-01 | 2019-10-08 |
| A Study of Eritoran (E5564) Administered IV Over 14 Days Prior to and During Bone Marrow Engraftment in BMT Patients Who Have Received Myeloablative Conditioning Treatment and Are Receiving Bone Marrow or Stem Cells From Matched Related Donors E5564 - Leukemia | Phase 1 | Terminated | Eisai Inc. | 30 | 2008-09-01 | 2014-07-11 |
Insulin Resistance (2) · COVID-19 (1) · Community-Acquired Pneumonia (1) · Graft vs Host Disease (1) · Influenza, Human (1) · Leukemia (1) · Lung Diseases (1) · Pneumonia (1) · Respiratory Tract Diseases (1) · Respiratory Tract Infections (1)
The University of Texas Health Science Center at San Antonio (2) · Eisai Inc. (1) · UMC Utrecht (1)
United States (4) · Australia (1) · Belgium (1) · Canada (1) · Colombia (1) · Croatia (1) · Czechia (1) · Estonia (1) · Finland (1) · France (1) · Germany (1) · Hungary (1) · India (1) · Ireland (1) · Israel (1)
Nicolas Musi, MD (2) · Colin McArthur, Dr (1) · Derek Angus, Prof (1) · John Marshall, Prof (1) · Kenneth Cooke (1) · Lennie Derde, MD (1) · Luis Felipe Reyes, MD, MSc, PhD (1) · Marc Bonten, Prof (1) · Steve Webb, Prof (1)
PMID 36066991, PMID 32267771, PMID 32876697, PMID 33394942, PMID 33509275, PMID 33631065, PMID 34251506, PMID 34351721, PMID 34351722, PMID 34473343, PMID 34606578, PMID 35315874, PMID 36525245, PMID 36942550, PMID 36967714, PMID 37039790, PMID 37256341, PMID 37489818, PMID 37877585, PMID 37888913, PMID 40261382, PMID 40360262, PMID 42823695
2015 (1), 2023 (1)